Upgrade to SI Premium - Free Trial

Immunogen, Inc. (IMGN) Misses Q3 Expectations

April 25, 2014 6:31 AM

Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.44), $0.17 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $13.28 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.

Categories

Earnings